Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Two-thirds of Turkish physicians use smartphones for work

And Manhattan Research says one third own or use a tablet for professional purposes

Turkish medical app İlaçlar

Nearly two-thirds of doctors in Turkey own or use a smartphone for professional purposes, and just over one third use a tablet at work, according to a new study.

Manhattan Research questioned 200 physicians in the country for its Taking the Pulse Turkey 2012 report and concluded Turkish physicians are using multiple screens for professional purposes.


Tip of the week

You've been tagged 

Commenting on the findings, Manhattan Research's vice president of research Monique Levy said: “Digital media and devices are increasingly integral to physicians' clinical workflow across high-growth markets like Turkey.

“Each market has its idiosyncrasies, creating opportunities for pharma to refine and localise their marketing strategies.”

Pharmaceutical companies have been aggressively investing in high-growth markets, such as Turkey, and are looking to digital channels to augment their sales and marketing efforts, Manhattan said.

Key findings from the company's new Turkey physician research include:

• Sixty four per cent of online physicians own or use a smartphone for professional purposes and 35 per cent own or use a tablet for professional purposes

• Online physicians in Turkey access the Internet throughout the workday - 60 per cent go online between patient consultations, most often to use drug reference databases and government resources

• Twenty three per cent of physicians surveyed said they participate in pharma online promotional programmes and 59 per cent said they would be interested in doing so

The top paid-for medical app in the Turkish iTunes Store is currently İlaçlar (iPad version pictured above), a drug resource for physicians, pharmacists and other healthcare professionals.

Costing $4.99, it provides information on drugs, their active ingredients, retail and public prices, packaging information and a barcode scanner.

Doctors' ownership of iPads and other tablets

The iPad figures for Turkey are broadly consistent with other European countries, according to earlier research by Manhattan, and speaking at a webcast earlier this week Levy noted that global device use was rapidly increasing.

“We know that devices have pretty strong penetrations across the markets and that device ownership, including tablets, is ramping up pretty quickly,” she said.

Prior research had found a ceiling to what physicians were willing to do on a smartphone, essentially using it as a research tool, but that will change, Levy said, with tablets.

Almost half of iPad owners plan to purchase another device within the next six months, but it's less important to them whether reps arrive with the latest iPad, Levy said.

Asked whether tablets were replacing other devices, Levy said: “We see a little bit of the desktop time moving to the iPad, but genrally what we see is that more screens means more access.”

But the research also showed that it's not all about the latest device. “Email is alive and well,” Levy noted, adding: “It's the most basic tactic, physicians are reading newsletters from pharma and they're communicating with reps.”

3rd August 2012

From: Marketing


Subscribe to our email news alerts


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Actinic keratosis – a common skin condition that can lead to skin cancer
PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
Man vs microbe: the fight against antimicrobial resistance
How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...